staceywhite, Author at European Medical Journal - Page 27 of 195

Clinical Updates on Cerliponase Alfa ▼ in Children with CLN2 Disease

This infographic details the presentation, progression, and treatment of neuronal ceroid lipofuscinosis Type 2 (CLN2 disease), a…

A Roadmap for Clear Skin

Notable recent additions to dermatologists’ acne toolkit include newer dual and triple combination therapies, as well as agents with…

Optimising Patient Outcomes in Advanced Gastrointestinal Stromal Tumours (GIST) in Europe

The European Society for Medical Oncology (ESMO) guidelines recommend life-long systemic tyrosine kinase inhibitor (TKI) therapies for…

Whipple’s Disease: One of Medicine’s Great Imitators

Following an admission to the authors’ centre with severe anaemia, duodenal biopsy confirmed the diagnosis of Whipple’s disease…

Retracted: Ozanimod▼ in Ulcerative Colitis: Key New Data

This article has now been retracted and a retraction statement has been published.

SAPIEN 3 Ultra RESILIA valve: 1-year real-world outcomes with significant mortality benefits for patients

SAPIEN 3 Ultra RESILIA valve shows significant 1-year benefits, including lower all-cause mortality (driven by lower PVL), stroke, and…

Benefit of Dual Immunotherapy in GI Cancers

This infographic summarises three ongoing studies that demonstrate the benefit of dual immunotherapy combination therapy compared…

Targeting Tau in Early Alzheimer’s Disease

Phase 2 randomised controlled trial (RCT) of BMS-986446, a monoclonal antibody targeting the tau microtubule binding region (MTBR)…

Better Lungs Symposium at ERS 2024

There is an urgent need to elevate the importance of good lung health among patients, healthcare professionals, the general public, policy…

Scientific Innovations from 2024

The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in medicine in 2024…